Challenges and Opportunities When Developing Devices for Rare Disease Populations
Expert Opinion on Orphan Drugs - United Kingdom
doi 10.1517/21678707.2016.1166948
Full Text
Open PDFAbstract
Available in full text
Date
March 25, 2016
Authors
Publisher
Informa Healthcare